Department of Developmental Psychiatry, University of Cambridge, Cambridge, UK.
J Intellect Disabil Res. 2013 Jun;57(6):531-8. doi: 10.1111/j.1365-2788.2012.01556.x. Epub 2012 Apr 25.
Patients with intellectual disabilities (ID) receive health care by proxy. It is family members and/or paid support staff who must recognise health problems, communicate with clinicians, and report the benefits, if any, of a particular treatment. At the same time international and national statutes protect and promote the right of people with disabilities to access the highest attainable standards of health on the basis of free and informed consent.
To consider the role of parent-proxies in the management of epilepsy in adult children with ID who are at risk of lacking capacity to make decisions about their health care we interviewed 21 mothers.
These mothers are not pursuing changes in treatment that might improve their son or daughter's epilepsy, nor are they willing to countenance changes in treatment. Clinicians concerned to build and sustain therapeutic alliances with these mothers, our evidence suggests, may well avoid going against their wishes.
Our research highlights the interactional contingencies of a hitherto neglected three-way clinical relationship comprising parent-proxy, an adult at risk of lacking decision-making capacity, and a treating clinician. This is a relationship, our findings suggest, where little importance is attached to either patient consent, or involvement in treatment decisions.
智障患者(ID)由代理人提供医疗服务。必须由家庭成员和/或付费支持人员来识别健康问题、与临床医生沟通,并报告特定治疗的任何益处。与此同时,国际和国家法规保护和促进残疾人在基于自由和知情同意的基础上获得最高可达健康标准的权利。
为了考虑父母代理人在管理有智力障碍的成年子女癫痫中的作用,这些子女有能力做出关于自己医疗保健的决策,我们采访了 21 位母亲。
这些母亲并没有寻求可能改善他们儿子或女儿癫痫的治疗方法的改变,也不愿意考虑改变治疗方法。我们的证据表明,关注与这些母亲建立和维持治疗联盟的临床医生可能会避免违背她们的意愿。
我们的研究强调了迄今为止被忽视的三方临床关系的互动条件,包括父母代理人、有决策能力缺陷风险的成年人和治疗临床医生。我们的研究结果表明,这种关系几乎不重视患者同意或参与治疗决策。